Home
About Us
About Imugene
Our People
Vision Statement
Corporate Profile
Linguet Technology
Market Opportunities
Linguet Pipeline
Linguet & Vitamin D
Linguet & Parkinsons Disease
Linguet & Pain Relief
Intellectual Property
Investor Centre
ASX Announcements
ASX Announcements 2013
ASX Announcements 2012
ASX Announcements 2011
ASX Announcements 2010
ASX Announcements 2009
ASX Announcements 2008
ASX Announcements Pre 2008
Annual Reports
Investor Presentations
Research & Analyst Reports
Media Monitoring
Newsletters
Corporate Governance
Contact Us
ASX Announcements 2008
31 December 2008
Imugene and Merial establish a Strategic Alliance
28 November 2008
Results of Annual General Meeting
28 November 2008
AGM Presentation
31 October 2008
Appendix 4C - quarterly
23 October 2008
Annual Report to shareholders
22 October 2008
Notice of Annual General Meeting/Proxy Form
13 October 2008
Change in substantial holding
10 October 2008
PRRS Final Trial Results
09 September 2008
Full Year Statutory Accounts
20 August 2008
PRRS Vaccine Trial Success
31 July 2008
Quarterly activity and cashflow reports
04 July 2008
Imugene's PRRS vaccine for pigs enters further trials
01 July 2008
Advisor Incentive Options - Appendix 3B
29 May 2008
Company Secretary Appointment/Resignation
15 May 2008
Poultry Coccidiosis Vaccine Trial Successful
30 April 2008
Quarterly Activities Update and Appendix 4C
07 April 2008
Cocci Vaccine Trial in Progress
29 February 2008
Half Yearly Report and Accounts
06 February 2008
Change of Director’s Interest Notice
06 February 2008
Change of Director’s Interest Notice
04 February 2008
Form 603 - Notice of initial substantial holder
01 February 2008
Change of Directors' Interests x3
31 January 2008
Appendix 3B - New Issue Announcement
31 January 2008
Quarterly Report to 31 December 2007
22 January 2008
Allotment Of Rights Issue Shares, Appendix 3B And s708A Notice
18 January 2008
Rights Issue - Notification of Shortfall